Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and Purpose— Extending the duration of continuous electrocardiography after ischemic stroke detects more new cases of atrial fibrillation, which is an important and treatable cause of stroke, but the cost-effectiveness of this approach is unknown. Therefore, we performed a cost-utility analysis of outpatient cardiac monitoring after ischemic stroke. Methods— Using a Markov model, we determined the lifetime cost and utility of warfarin therapy in a hypothetical cohort of 70-year-old patients with atrial fibrillation, prior stroke, and no contraindication to warfarin therapy. Meta-analysis was used to determine the yield of outpatient cardiac monitoring. Results— Outpatient cardiac monitoring would detect 44 new cases of atrial fibrillation for every 1000 patients monitored. This would result in a gain of 34 quality-adjusted life-years at a net cost of $440 000. Therefore, the cost-utility ratio of outpatient cardiac monitoring would be $13 000 per quality-adjusted life-years gained. Outpatient monitoring remained cost-effective throughout a wide range of model inputs in sensitivity analyses, including changes in the cost and yield of monitoring. Conclusions— By identifying patients with paroxysmal atrial fibrillation who will benefit from anticoagulation, outpatient cardiac monitoring is cost-effective after ischemic stroke over a wide range of model inputs. The optimal duration and method of monitoring is unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · cited 1×
“预防 AF 的方法,如直接凝血酶抑制剂 dabigatran([49]) 和经皮关闭左房心耳的设备 ([50]),可是在临床上这些”
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Savelieva, I., & Camm, A. J. (2000) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1009823001707 · Cited by 339 · cited 1×
“Monitoring may (1) reveal AF that would never have been diagnosed; (2) reveal AF that would eventually have been diagnosed by other means; (3) truly rule out AF; (4) fail to reveal AF that then remains undiagnosed; and (5) fail to reveal AF that is eventually diagnosed by other means.”
BackgroundLiao, J., Khalid, Z., Scallan, C., Morillo, C., & O’Donnell, M. (2007) · Stroke · doi:10.1161/strokeaha.106.478685 · Cited by 331
Paciaroni, M., Agnelli, G., Micheli, S., & Caso, V. (2007) · Stroke · doi:10.1161/01.str.0000254600.92975.1f · Cited by 307 · cited 1×
“9%([54])。虽然在 最初几周内心脏监测不会改变 AF 的治疗——这包 括实际原因 ( 需要时间来获得并整理监测结果,然 后获得抗凝治疗的合适剂量 ) 和安全性原因 ( 伴 AF 的卒中患者的急性期抗凝治疗出血风险增高 ([55])),但”
Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
Linzer, M., Pritchett, E. L. C., Pontinen, M., McCarthy, E., & Divine, G. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90591-n · Cited by 239
Zimetbaum, P. J., Kim, K. Y., Josephson, M. E., Goldberger, A. L., & Cohen, D. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00002 · Cited by 133
Cited by
Atrial fibrillation in patients with cryptogenic stroke
Gladstone, D. J., Spring, M., Dorian, P., Panzov, V., Thorpe, K. E., Hall, J., Vaid, H., O'Donnell, M., Laupacis, A., Côté, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311376 · Cited by 1,276
Seet, R. C. S., Friedman, P. A., & Rabinstein, A. A. (2011) · Circulation · doi:10.1161/circulationaha.111.029801 · Cited by 276
Grond, M., Jauss, M., Hamann, G., Stark, E., Veltkamp, R., Nabavi, D., Horn, M., Weimar, C., Köhrmann, M., Wachter, R., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001884 · Cited by 229
Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., & Houben, R. P. (2014) · Europace · doi:10.1093/europace/euu057 · Cited by 138
Metadata
- Authors
- Kamel, H., Hegde, M., Johnson, D. R., Gage, B. F., & Johnston, S. C.
- Venue
- Stroke
- Published
- 2010-07
- Volume
- 41
- Issue
- 7
- Pages
- 1514-1520
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2144088986
- Cited by
- 82
- References
- 12
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.